Expression of concern
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
Paper Information
Record ID:
34204
Author(s):
Journal:
Publication Date:
August 14, 2020
Retraction Date:
October 11, 2021
(4.1 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt
- Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Internal Medicine, Ain-Shams University, Cairo, Egypt
- Public Health and Community Medicine, Menoufia University, Menoufia, Egypt
- Department of Forensic Medicine and Toxicology, Faculty of Medicine, Tanta University, Tanta, Egypt
- Department of Internal Medicine, Al-Azhar University, Cairo, Egypt
Country:
🇪🇬 EgyptArticle Type:
Publisher:
American Society of Tropical Medicine and Hygiene
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.4269/ajtmh.20-0873Citations (137)
137
Total Citations45
Post-Retraction(32.8%)
92
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
28
Within 1 year
4
After 2+ years
1294
Days since retraction (latest)
EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
Alessia Alunno, Aurélie Najm, Pedro Machado et al. (24 authors)
Annals of the Rheumatic Diseases
Open Access
Published: Feb 2021
38 citations
38 citations
248 days before retraction
Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
Pawan Sharma, Kielan Darcy McAlinden, Saeid Ghavami et al. (4 authors)
European Journal of Pharmacology
Open Access
Published: Feb 2021
21 citations
21 citations
250 days before retraction
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
Waleed Alhazzani, Laura Evans, Fayez Alshamsi et al. (47 authors)
Critical Care Medicine
Open Access
Published: Jan 2021
370 citations
370 citations
256 days before retraction
From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
Stav Rakedzon, Ami Neuberger, Abraham J. Domb et al. (5 authors)
Journal of Travel Medicine
Open Access
Published: Jan 2021
41 citations
41 citations
271 days before retraction
Analysis of COVID-19 Guideline Quality and Change of Recommendations: A Systematic Review
Siya Zhao, Shuya Lu, Shouyuan Wu et al. (26 authors)
Health Data Science
Open Access
Published: Jan 2021
10 citations
10 citations
283 days before retraction
An altmetric study: Social attention based evaluation of top-100 publications about the COVID-19 pandemic from notification of the first case to the 6th month
Mehmet Dokur, Nuket GÜLER BAYSOY, Betül Börkü Uysal et al. (5 authors)
Turkish Bulletin of Hygiene and Experimental Biology
Open Access
Published: Jan 2021
3 citations
3 citations
283 days before retraction
CLINICAL MANAGEMENT OF PATIENTS WITH COVID-19. “LIVE” CLINICAL INSTRUCTION (2021)
Садов’як Ірина Дмитрівна
ДЕРЖАВНА НАУКОВА УСТАНОВА «НАУКОВО-ПРАКТИЧНИЙ ЦЕНТР ПРОФІЛАКТИЧНОЇ І КЛІНІЧНОЇ МЕДИЦИНИ» eBooks
Open Access
Published: Jan 2021
4 citations
4 citations
283 days before retraction
Acyclovir As a Potential Add-On Treatment for COVID-19; A Narrative Review
Fatemeh Heidary, Sedigheh Madani, Reza Gharebaghi et al. (4 authors)
SSRN Electronic Journal
Published: Jan 2021
6 citations
6 citations
283 days before retraction
TBHEB 2021-4 Vol 78 Full Printed Journal
Utku ERCÖMERT
Turkish Bulletin of Hygiene and Experimental Biology
Open Access
Published: Jan 2021
283 days before retraction
Optimized chloroquine phosphate dosage regimens for early virological clearance of severe acute respiratory syndrome coronavirus 2 using Monte Carlo simulation
Nattapong Tidwong, Baralee Punyawudho, Pannee Leelawattanachai et al. (8 authors)
Deleted Journal
Open Access
Published: Jan 2021
2 citations
2 citations
283 days before retraction
Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
Paul Eze, Kenechukwu Mezue, Chidozie Nduka et al. (5 authors)
PubMed
Published: Jan 2021
23 citations
23 citations
283 days before retraction
Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery
Chen Yao, Meixiu Li, Guo‐Dong Lu et al. (5 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2021
38 citations
38 citations
283 days before retraction
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
Sun Bean Kim, Seungeun Ryoo, Kyungmin Huh et al. (20 authors)
Infection and Chemotherapy
Open Access
Published: Jan 2021
26 citations
26 citations
283 days before retraction
Japanese rapid/living recommendations on drug management for COVID‐19
Kazuma Yamakawa, Ryo Yamamoto, Go Ishimaru et al. (23 authors)
Acute Medicine & Surgery
Open Access
Published: Jan 2021
15 citations
15 citations
283 days before retraction
A Systematic Review and Network Meta-Analysis for COVID-19 Treatments
Chenyang Zhang, Huaqing Jin, Yi Feng Wen et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2020
2 citations
2 citations
293 days before retraction
Current evidence for COVID-19 therapies: a systematic literature review
Tobias Welte, Lucy Ambrose, Gillian C. Sibbring et al. (6 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2020
3 citations
3 citations
296 days before retraction
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of <i>in vitro</i>, <i>in vivo</i>, and clinical trials
Young Joo Han, Keum Hwa Lee, Sojung Yoon et al. (25 authors)
Theranostics
Open Access
Published: Dec 2020
26 citations
26 citations
299 days before retraction
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
Mohammed Alghamdi, Nasser Aljuhani, Afrah AL- Somali et al. (13 authors)
International Journal of Coronaviruses
Open Access
Published: Dec 2020
301 days before retraction
Covid-19: Urgent Call to Action
Amal Ahmed Mohamed, Omnia I. Tantawi, Lamiaa Abdelfattah Fathalla et al. (9 authors)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Published: Dec 2020
3 citations
3 citations
312 days before retraction
Recomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19)
Jorge Pérez Godoy, Ruth Rosales Chacón, Fernando Bernal Ortiz et al. (19 authors)
Revista chilena de infectología
Open Access
Published: Dec 2020
314 days before retraction
Recomendaciones para el diagnóstico y manejo farmacológico en pacientes pediátricos con infección por SARS-CoV-2 (COVID-19)
Daniela Pavez Azurmendi, Claudio González Muñoz, Fernando Bernal Ortiz et al. (14 authors)
Revista chilena de infectología
Open Access
Published: Dec 2020
314 days before retraction
Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining methodological quality
Kimia Honarmand, J.B. Penn, Arnav Agarwal et al. (19 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Nov 2020
315 days before retraction
RETRACTED ARTICLE: Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial
Sherief Abd‐Elsalam, Shaimaa Soliman, Eslam Saber Esmail et al. (10 authors)
Biological Trace Element Research
Open Access
Published: Nov 2020
85 citations
85 citations
318 days before retraction
Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul, Emil Eik Nielsen, Joshua Feinberg et al. (15 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Nov 2020
7 citations
7 citations
321 days before retraction
The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis
Amir Shamshirian, Amirhossein Hessami, Keyvan Heydari et al. (18 authors)
Annals of the Academy of Medicine Singapore
Open Access
Published: Nov 2020
11 citations
11 citations
325 days before retraction
Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome
Rana Kadry, Andrea Sikora, Payaningal R. Somanath
Infectious Disorders - Drug Targets
Open Access
Published: Nov 2020
16 citations
16 citations
328 days before retraction
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review
Immacolata Faraone, Fabiana Labanca, Maria Ponticelli et al. (5 authors)
Molecules
Open Access
Published: Nov 2020
12 citations
12 citations
331 days before retraction
The Role of Hydroxychloroquine in COVID-19 Treatment: A Systematic Review and Meta-Analysis
Amir Shamshirian, Amirhossein Hessami, Keyvan Heydari et al. (18 authors)
Annals of the Academy of Medicine Singapore
Open Access
Published: Nov 2020
10 citations
10 citations
331 days before retraction
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
Mathieu Gendrot, Julien Andréani, Priscilla Jardot et al. (14 authors)
Molecules
Open Access
Published: Oct 2020
89 citations
89 citations
345 days before retraction
Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
Joshua P. Vogel, Britta Tendal, Michelle Giles et al. (24 authors)
Australian and New Zealand Journal of Obstetrics and Gynaecology
Open Access
Published: Oct 2020
43 citations
43 citations
347 days before retraction
Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti et al. (5 authors)
Annals of Internal Medicine
Open Access
Published: Oct 2020
27 citations
27 citations
355 days before retraction
Analysis of the <scp>US FDA</scp> adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults
Prasad S. Nishtala, Sakirat Gill, Te‐yuan Chyou
Pharmacoepidemiology and Drug Safety
Open Access
Published: Oct 2020
11 citations
11 citations
356 days before retraction
Has the door closed on hydroxychloroquine for SARS-COV-2?
Mical Paul
Clinical Microbiology and Infection
Open Access
Published: Oct 2020
7 citations
7 citations
356 days before retraction
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
Faizan Mazhar, Muhammad Abdul Hadi, Chia Siang Kow et al. (6 authors)
International Journal of Infectious Diseases
Open Access
Published: Sep 2020
12 citations
12 citations
377 days before retraction
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud et al. (94 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2020
56 citations
56 citations
388 days before retraction
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
Mathieu Gendrot, Julien Andréani, Manon Boxberger et al. (13 authors)
Travel Medicine and Infectious Disease
Open Access
Published: Sep 2020
103 citations
103 citations
405 days before retraction
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica J Bartoszko, Dena Zeraatkar et al. (52 authors)
BMJ
Open Access
Published: Jul 2020
810 citations
810 citations
438 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #39037
Sep 02, 2022Quick Stats
Total Citations:
137
Years Since Retraction:
4.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025